The association between metformin therapy and risk of gynecological cancer in patients: two meta-analyses
ConclusionsThe results suggested the metformin can be used as a potential anticarcinogenic drug for gynecological cancers’ prevention, especially for Asians and cervical cancer. The question remains, still, whether metformin is beneficial for ovarian cancer. Also, we don't know whether it is worth to give metformin to non-diabetes to prevent gynecological cancer.
Source: European Journal of Obstetrics and Gynecology and Reproductive Biology - Category: OBGYN Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Cervical Cancer | Databases & Libraries | Diabetes | Diabetes Type 2 | Endocrinology | Endometrial Cancer | Epidemiology | Fortamet | Metformin | OBGYN | Ovarian Cancer | Ovaries | Statistics | Study